ENT.AX Enterprise Metals ASX up 25.00% intraday 21 Feb 2026: watch volume and 3‑year upside
ENT.AX stock is trading as a top gainer intraday on the ASX after a 25.00% rise to A$0.005 on 21 Feb 2026, with volume 7,276,712.00 shares. The move follows renewed interest in explorer Enterprise Metals Limited (ENT.AX) as market participants re-rate small-cap Basic Materials names. Enterprise Metals holds tenements in the Murchison, Doolgunna and Fraser Range regions of Western Australia. For traders the jump on high volume signals momentum, while fundamentals and low liquidity keep risk elevated for investors seeking a recovery play.
ENT.AX stock intraday price action and volume
ENT.AX stock is up 25.00% intraday, moving from the previous close of A$0.004 to an intraday high of A$0.005 and a low of A$0.004. Reported volume is 7,276,712.00 versus an average volume of 1,161,463.00, indicating above-normal trading interest in this ASX microcap.
Advertisement
The surge accounts for a short-term relative strength: 1‑day change registers 25.00% and year‑to‑date change is 25.00%. Traders should note the thin free float and 1,494,150,586.00 shares outstanding, which can magnify moves in either direction.
ENT.AX stock fundamentals and financials
Enterprise Metals Limited (ENT.AX) is classified in Basic Materials on the ASX and focuses on base and precious metal exploration in Western Australia. Market cap is A$7,470,753.00 and book value per share is A$0.00354.
Key ratios show mixed fundamentals: price to book is 1.41, price to sales is 714.29, and trailing PE is not meaningful because EPS is negative. Cash per share is A$0.00057 and current ratio TTM is 0.69, reflecting limited working capital relative to short-term obligations.
ENT.AX stock technicals and trading signals
Technical indicators support a short-term momentum bias: RSI is 63.98, ADX is 53.32 signalling a strong trend, and the 50‑day average sits at A$0.00430 versus the current A$0.005. On‑balance volume (OBV) of 8,071,101.00 confirms buying pressure.
Volatility is typical for microcaps; Bollinger upper band is around A$0.010. Use tight risk controls: ATR is nominal but liquidity can evaporate, so set stop losses relative to liquidity and position size.
ENT.AX stock Meyka AI rates and valuation
Meyka AI rates ENT.AX with a score out of 100: 60.54 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Independent company rating data (20 Feb 2026) shows a C+ external rating with mixed metric scores. Price/book at 1.41 gives some asset backing, but negative margins and low cash per share limit valuation support for a BUY thesis.
ENT.AX stock catalysts, risks and sector context
Catalysts for ENT.AX stock include exploration results from Murchison, Doolgunna or Fraser Range projects and any announced farm‑out or JV deals that derisk targets. In the Basic Materials sector, larger miners have pushed commodity interest higher, which can lift explorer sentiment; the sector is up 12.62% over three months regionally.
Major risks: speculative exploration outcomes, limited liquidity, negative cash flow metrics (operating cash flow per share -0.00044) and thin balance sheet buffers. Corporate news or drilling updates will likely drive further intraday volatility.
ENT.AX stock price forecasts and analyst outlook
Meyka AI’s forecast model projects a near‑term yearly price of A$0.00540, three‑year A$0.00705, five‑year A$0.00870, and seven‑year A$0.01065. The one‑year projection implies +7.98% upside from the current A$0.005.
Analyst consensus coverage is sparse; no formal price target consensus is listed. Given fundamentals, a realistic trading range over 12 months is A$0.003–A$0.010, with company news and drilling updates as the main drivers.
Final Thoughts
ENT.AX stock stands out among ASX top gainers today after a 25.00% intraday rise to A$0.005, driven by heavy volume 7,276,712.00 and renewed speculative interest in explorers. Our technical read shows momentum but fundamentals remain weak: negative EPS, low cash per share and a current ratio below 1. Meyka AI’s forecast model projects a one‑year price of A$0.00540 (implied upside 7.98%) and a three‑year target of A$0.00705 (implied upside 40.97%). Meyka AI rates ENT.AX with a score out of 100: 60.54 (Grade B, HOLD), reflecting mixed sector tailwinds versus company‑level risks. Traders may consider short‑term setups on momentum, while longer‑term investors should wait for clearer exploration results or a stronger liquidity profile. Forecasts are model‑based projections and not guarantees. For company details visit the Enterprise Metals website and see market data on FinancialModelingPrep. For live quotes and position tracking use our Meyka stock page.
Advertisement
FAQs
What caused the intraday rise in ENT.AX stock today?
The intraday rise to A$0.005 (up 25.00%) was driven by above‑average volume of 7,276,712.00 shares and renewed speculative buying in exploration microcaps. No major corporate announcement has been reported; drill results or deal rumours commonly trigger such moves.
What is Meyka AI’s short‑term forecast for ENT.AX stock?
Meyka AI’s model projects a one‑year price of A$0.00540 for ENT.AX stock, an implied upside of 7.98% from the current A$0.005. Forecasts are model outputs and not guarantees.
Is ENT.AX stock a buy for long‑term investors?
ENT.AX stock currently shows speculative upside but weak fundamentals: negative EPS, low cash per share and limited liquidity. Meyka AI grades ENT.AX B (HOLD). Long‑term investors should wait for stronger cash flow, clear exploration success or strategic partnerships before buying.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)